Bilans d’évènement
Life Science Committee meeting with Danish Industry on MDR
Discussions emphasized that the future of the industry in Europe depends on decisions made today, especially in a global context shaped by the rising.
On Wednesday April 15, the Danish French Chamber of Commerce had the pleasure to host the Life Science Committee x Danish Industry on his HQ.
The meeting highlighted how heavy bureaucracy and regulatory fragmentation, especially under the Medical Device Regulation (MDR), are weakening the competitiveness of the EU Life Sciences industry.
Uncertainty, driven by complex rules, geopolitical tensions, and global competition shaped by the rising competitiveness of China and increasingly protectionist policies in the United States, was identified as the main barrier to investment and growth.
While the European Commission is considering a shift toward less regulation and greater efficiency, concrete changes are unlikely before 2028. Participants stressed the urgent need for faster action to support innovation, improve patient access, and ensure Europe remains competitive globally.
Thank you to all participants for contributing to this enriching discussion.
